Announcement on Implementation of Q1-Q3 2024 Dividend Distribution
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Implementation of Q1-Q3 2024 Dividend Distribution
Filed with SSE · · 4 pages · Chinese
Release
Hangzhou Biotest Biotech Co., Ltd. on 6ix
Earlier from Hangzhou Biotest Biotech
- Announcement on Change of the Signing Accountant
- Announcement on Adjusting Profit Distribution Plan for Q1-Q3 2024
- Announcement on Completion of Non-trading Transfer under 2024 Employee Stock Ownership Plan
- Announcement on Departure of Core Technical Personnel
- Announcement on Opening Special Settlement Account for Cash Management Using Raised Funds
Later from Hangzhou Biotest Biotech
- Notice on Convening the 1st Extraordinary General Meeting in 2025
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Announcement on Share Reduction Plan for Directors and Senior Executives
- Announcement on Preliminary Earnings Estimate for 2024
- Announcement on Provision for Asset Impairment and Write-off of Assets in 2024
Follow Hangzhou Biotest Biotech into a list and get an email when it puts out news.
Follow Hangzhou Biotest Biotech